Wondemagegn Mulu1, Daniel Mekonnen1, Mulat Yimer1, Aschalew Admassu2, Bayeh Abera1. 1. Department of Medical Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Bahir Dar University, Ethiopia. 2. Department of Regional Mycobacteriology Laboratory, Bahir Dar Regional Health Research Laboratory Center, Bahir Dar, Ethiopia.
Abstract
BACKGROUND: Multidrug resistant tuberculosis(MDR-TB) is becoming a major threat to tuberculosis control programs in Ethiopia. OBJECTIVES: To determine risk factors of MDR-TB patients in Amhara National Regional State, Ethiopia. METHODS: Case-control study was conducted from May 2013 to January 2014. Resistance to rifampicin and isoniazid were done molecularly using line probe assay. TB patients infected with MDR-M.tuberculosis and non MDR-M.tuberculosis strain were considered as cases and controls, respectively. Data was collected using structured questionnaire with face to face interview. Patients' clinical record review was also done.Multivariate analysis was computed to determine the risk factors of MDR-TB. RESULTS: A total of 153 MDR-TB and equal number of non MDR-TB patients' participated in the study. Patients who had TB treatment failure (AOR=13.5,CI=2.69-70), cavitations on chest x-ray (AOR=1.9,CI=1.1-3.38) and contact with MDR-TB patients (AOR=1.4,CI=0.19-0.39) were more likely to be MDR-TB patients. Low monthly income (AOR=1.1,CI=0.34-0.47),alcohol consumption (AOR=1.5,CI=0.2-0.98) and young age (AOR=2.9,CI=1.07-7.68) were the other risk factors of MDR-TB. CONCLUSIONS: TB treatment failure, cavitation on chest X-ray, contact with MDR-TB patients and low socioeconomic status were important risk factors for development of MDR-TB. Therefore, strict adherence to directly observed therapy, appropriate management of TB patients and advice on the value of nutrients are helpful to control the spreading of MDR-TB.
BACKGROUND: Multidrug resistant tuberculosis(MDR-TB) is becoming a major threat to tuberculosis control programs in Ethiopia. OBJECTIVES: To determine risk factors of MDR-TB patients in Amhara National Regional State, Ethiopia. METHODS: Case-control study was conducted from May 2013 to January 2014. Resistance to rifampicin and isoniazid were done molecularly using line probe assay. TB patients infected with MDR-M.tuberculosis and non MDR-M.tuberculosis strain were considered as cases and controls, respectively. Data was collected using structured questionnaire with face to face interview. Patients' clinical record review was also done.Multivariate analysis was computed to determine the risk factors of MDR-TB. RESULTS: A total of 153 MDR-TB and equal number of non MDR-TB patients' participated in the study. Patients who had TB treatment failure (AOR=13.5,CI=2.69-70), cavitations on chest x-ray (AOR=1.9,CI=1.1-3.38) and contact with MDR-TB patients (AOR=1.4,CI=0.19-0.39) were more likely to be MDR-TB patients. Low monthly income (AOR=1.1,CI=0.34-0.47),alcohol consumption (AOR=1.5,CI=0.2-0.98) and young age (AOR=2.9,CI=1.07-7.68) were the other risk factors of MDR-TB. CONCLUSIONS:TB treatment failure, cavitation on chest X-ray, contact with MDR-TB patients and low socioeconomic status were important risk factors for development of MDR-TB. Therefore, strict adherence to directly observed therapy, appropriate management of TB patients and advice on the value of nutrients are helpful to control the spreading of MDR-TB.
Authors: Muayad Aghali Merza; Parissa Farnia; Payam Tabarsi; Mehdi Khazampour; Mohammad Reza Masjedi; Ali Akbar Velayati Journal: J Infect Dev Ctries Date: 2011-07-27 Impact factor: 0.968
Authors: Philip M Ricks; Farai Mavhunga; Surbhi Modi; Rosalia Indongo; Abbas Zezai; Lauren A Lambert; Nick DeLuca; Jamie S Krashin; Allyn K Nakashima; Timothy H Holtz Journal: BMC Infect Dis Date: 2012-12-29 Impact factor: 3.090
Authors: Kelly E Dooley; Ouafae Lahlou; Iraqi Ghali; Janine Knudsen; My Driss Elmessaoudi; Imad Cherkaoui; Rajae El Aouad Journal: BMC Public Health Date: 2011-02-28 Impact factor: 3.295
Authors: Gustavo E Velásquez; Martin Yagui; J Peter Cegielski; Luis Asencios; Jaime Bayona; Cesar Bonilla; Hector O Jave; Gloria Yale; Carmen Suárez; Sidney Atwood; Carmen C Contreras; Sonya S Shin Journal: Emerg Infect Dis Date: 2011-03 Impact factor: 6.883
Authors: Jason E Farley; Malathi Ram; William Pan; Stacie Waldman; Gail H Cassell; Richard E Chaisson; Karin Weyer; Joey Lancaster; Martie Van der Walt Journal: PLoS One Date: 2011-07-22 Impact factor: 3.240
Authors: Yì Xiáng J Wáng; Myung Jin Chung; Aliaksandr Skrahin; Alex Rosenthal; Andrei Gabrielian; Michael Tartakovsky Journal: Quant Imaging Med Surg Date: 2018-03
Authors: Maha Al Ammari; Abdulrahman Al Turaiki; Mohammed Al Essa; Abdulhameed M Kashkary; Sara A Eltigani; Anwar E Ahmed Journal: Antimicrob Resist Infect Control Date: 2018-01-22 Impact factor: 4.887